Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision

NCT01053858 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.

NCT NCT01053858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01053858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision
Lead sponsor
Hallym University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2008
Completion date
January 31, 2010
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion with 20/200 or worse visual acuity